236 POSTER Phase I clinical trial of the 2nd generation proteasome inhibitor NPI-0052 in patients with advanced malignancies with a CLL RP2D cohort

✍ Scribed by A. Townsend; P. Padrik; P. Mainwaring; T. Price; L. Catley; A. Longenecker; M.A. Palladino; G.K. Lloyd; M.A. Spear; M. Millward

• Book ID: 119599391
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 59 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(08)72168-2